Kintor Pharmaceutical Limited (KNTPF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -42.22 Million CNY | 0.0% |
| 2022 | - CNY | -100.0% |
| 2021 | 34.23 Million CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 9000.00 CNY | -93.56% |
| 2017 | 139.75 Thousand CNY | -87.15% |
| 2016 | 1.08 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 78.11 USD | 100.0% |
| 2024 Q2 | 77.61 USD | -0.65% |
| 2023 FY | -42.22 Million CNY | 0.0% |
| 2023 Q3 | -2892.00 USD | 99.79% |
| 2023 Q1 | - USD | 100.0% |
| 2023 Q2 | -1.39 Million USD | 0.0% |
| 2023 Q4 | -7.12 Million USD | -246409.38% |
| 2022 Q4 | -1.4 Million USD | 0.0% |
| 2022 FY | - CNY | -100.0% |
| 2022 Q2 | -1.31 Million USD | 0.0% |
| 2021 Q4 | 5.31 Million USD | 0.0% |
| 2021 FY | 34.23 Million CNY | 0.0% |
| 2021 Q2 | -701.48 Thousand USD | 0.0% |
| 2020 Q4 | -570.96 Thousand USD | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q2 | -374.71 Thousand USD | 0.0% |
| 2019 Q2 | -315.73 Thousand USD | 0.0% |
| 2019 Q4 | -359.22 Thousand USD | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2018 FY | 9000.00 CNY | -93.56% |
| 2017 FY | 139.75 Thousand CNY | -87.15% |
| 2016 FY | 1.08 Million CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 8853.34% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 10395.613% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 460.747% |
| GB Sciences, Inc. | -624.00 USD | -6767367.949% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -33886.849% |
| Zenith Capital Corp. | - USD | Infinity% |
| Agentix Corp. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -1731306.314% |
| Biomind Labs Inc. | -15.42 Thousand USD | -273687.604% |
| ContraFect Corporation | -154 Thousand USD | -27321.429% |
| CSL Limited | 7.56 Billion USD | 100.559% |
| CytoDyn Inc. | -29 Thousand USD | -145517.241% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | -63.691% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -87404.921% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -123557.394% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 24017.648% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 135.455% |
| SQZ Biotechnologies Company | 9.79 Million USD | 531.172% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 67963.915% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 381.545% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 64348.113% |
| Mesoblast Limited | -35.16 Million USD | -20.078% |
| Marizyme, Inc. | 457.7 Thousand USD | 9326.309% |
| Genus plc | 178.7 Million USD | 123.631% |
| Pharming Group N.V. | 220.1 Million USD | 119.186% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -383800.0% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 55113.614% |
| IMV Inc. | -962.29 Thousand USD | -4288.35% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -10797.778% |
| MultiCell Technologies, Inc. | 49.32 USD | 85622565.531% |
| ONE Bio Corp. | 20.12 Million USD | 309.829% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 204.878% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 249.457% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | -3599.197% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 60427.143% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -852666.559% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 30156.228% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -48987.506% |
| Enzolytics Inc. | 30.7 Thousand USD | 137617.911% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 103.81% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -8107.615% |
| Genscript Biotech Corporation | 409.55 Million USD | 110.311% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 1361447.518% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -476740.56% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -50263.153% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -84358.0% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 4374.272% |
| EV Biologics, Inc. | 48.9 Thousand USD | 86457.873% |
| Q BioMed Inc. | -8988.00 USD | -469737.561% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 539.382% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 195.201% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | 373.773% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -43205.133% |
| HST Global, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -20302303.846% |
| Resverlogix Corp. | - USD | Infinity% |
| Cell Source, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 6939.989% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | -6601.548% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -356714.533% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 24017.648% |
| Affymax, Inc. | 1.35 Million USD | 3211.61% |
| Itoco Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 1016.428% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -8285.00 USD | -509604.285% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 9483.326% |
| SYBLEU INC | 11.69 Thousand USD | 361155.062% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -13116.925% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -11221.448% |
| Neutra Corp. | 14.33 Thousand USD | 294686.676% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -51398.78% |
| PureTech Health plc | -1.6 Million USD | -2534.373% |
| Coeptis Therapeutics, Inc. | -1 Million USD | -4117.687% |
| IXICO plc | 3.27 Million USD | 1391.407% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -5984.87% |
| Gelesis Holdings, Inc. | -1.79 Million USD | -2257.845% |
| CSL Limited | 7.7 Billion USD | 100.548% |
| Cellectis S.A. | 18 Thousand USD | 234705.556% |